Great Lakes Advisors’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.48M	Sell	65,581 -4,702	-7%	-$104K	0.01%	468
2025 Q4	$1.82M	Sell	70,283 -35,460	-34%	-$843K	0.01%	436
2025 Q3	$2.72M	Sell	105,743 -111,318	-51%	-$2.73M	0.02%	379
2025 Q2	$5.19M	Sell	217,061 -18,100	-8%	-$456K	0.04%	279
2025 Q1	$5.84M	Sell	235,161 -1,391	-0.6%	-$33.3K	0.05%	256
2024 Q4	$4.46M	Sell	236,552 -233,540	-50%	-$4.1M	0.04%	337
2024 Q3	$7.07M	Buy	+470,092	New	+$8.04M	0.06%	253
2022 Q3	–	Sell	-153,238	Closed	-$8.93M	–	697
2022 Q2	$8.93M	Sell	153,238 -6,078	-4%	-$398K	0.18%	149
2022 Q1	$12.2M	Sell	159,316 -37,564	-19%	-$2.5M	0.2%	139
2021 Q4	$11.8M	Sell	196,880 -4,108	-2%	-$227K	0.18%	162
2021 Q3	$11.3M	Sell	200,988 -7,166	-3%	-$413K	0.18%	169
2021 Q2	$12.6M	Sell	208,154 -7,688	-4%	-$487K	0.19%	163
2021 Q1	$15.1M	Buy	215,842 +16,258	+8%	+$1.16M	0.24%	137
2020 Q4	$11.9M	Sell	199,584 -8,760	-4%	-$513K	0.22%	133
2020 Q3	$12.5M	Buy	208,344 +31,591	+18%	+$1.84M	0.27%	122
2020 Q2	$9.27M	Buy	176,753 +12,705	+8%	+$531K	0.23%	123
2020 Q1	$5.5M	Sell	164,048 -215	-0.1%	-$8.93K	0.16%	156
2019 Q4	$7.44M	Buy	+164,263	New	+$6.98M	0.16%	164
2017 Q4	–	Sell	-122,083	Closed	-$4.58M	–	601
2017 Q3	$4.58M	Buy	122,083 +10,327	+9%	+$416K	0.11%	164
2017 Q2	$5.33M	Sell	111,756 -1,705	-2%	-$79.1K	0.13%	149
2017 Q1	$5.17M	Buy	113,461 +48,830	+76%	+$2.11M	0.13%	143
2016 Q4	$2.09M	Sell	64,631 -656	-1%	-$21.9K	0.05%	263
2016 Q3	$2.23M	Buy	+65,287	New	+$2.56M	0.06%	252